/PRNewswire/ — CollPlant Biotechnologies (NASDAQ: CLGN), or ‘CollPlant’, a regenerative and aesthetics medicine company developing innovative technologies and…Read More
CollPlant Expands the Distribution of its VergenixSTR Product in Europe
Related Posts
Add A Comment
